|Mammalian heart renewal by pre-existing cardiomyocytes.|
|Jump to Full Text|
|PMID: 23222518 Owner: NLM Status: MEDLINE|
|Although recent studies have revealed that heart cells are generated in adult mammals, the frequency of generation and the source of new heart cells are not yet known. Some studies suggest a high rate of stem cell activity with differentiation of progenitors to cardiomyocytes. Other studies suggest that new cardiomyocytes are born at a very low rate, and that they may be derived from the division of pre-existing cardiomyocytes. Here we show, by combining two different pulse-chase approaches--genetic fate-mapping with stable isotope labelling, and multi-isotope imaging mass spectrometry--that the genesis of cardiomyocytes occurs at a low rate by the division of pre-existing cardiomyocytes during normal ageing, a process that increases adjacent to areas of myocardial injury. We found that cell cycle activity during normal ageing and after injury led to polyploidy and multinucleation, but also to new diploid, mononucleate cardiomyocytes. These data reveal pre-existing cardiomyocytes as the dominant source of cardiomyocyte replacement in normal mammalian myocardial homeostasis as well as after myocardial injury.|
|Samuel E Senyo; Matthew L Steinhauser; Christie L Pizzimenti; Vicky K Yang; Lei Cai; Mei Wang; Ting-Di Wu; Jean-Luc Guerquin-Kern; Claude P Lechene; Richard T Lee|
Related Documents :
|6802478 - The cost-effectiveness of myocardial revascularization.
23405158 - Soluble tnf receptors are associated with infarct size and ventricular dysfunction in s...
12800408 - Percutaneous intervention of unprotected left main coronary artery.
12439438 - Angiogenesis.
23171718 - Current concepts in diagnosis and perioperative management of carcinoid heart disease.
22926488 - Extracellular matrix and fibroblast communication following myocardial infarction.
|Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't Date: 2012-12-05|
|Title: Nature Volume: 493 ISSN: 1476-4687 ISO Abbreviation: Nature Publication Date: 2013 Jan|
|Created Date: 2013-01-17 Completed Date: 2013-03-04 Revised Date: 2013-07-19|
Medline Journal Info:
|Nlm Unique ID: 0410462 Medline TA: Nature Country: England|
|Languages: eng Pagination: 433-6 Citation Subset: IM|
|Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Cambridge, Massachusetts 02139, USA.|
|APA/MLA Format Download EndNote Download BibTex|
DNA / biosynthesis
Myoblasts, Cardiac / cytology
Myocardial Infarction / genetics, metabolism, pathology
Myocardium / cytology*, metabolism, pathology
Myocytes, Cardiac / cytology*, metabolism
|AG032977/AG/NIA NIH HHS; AG034641/AG/NIA NIH HHS; AG040019/AG/NIA NIH HHS; EB001974/EB/NIBIB NIH HHS; F32 HL108570/HL/NHLBI NIH HHS; F32 HL108570/HL/NHLBI NIH HHS; K08 DK090147/DK/NIDDK NIH HHS; P41 EB001974/EB/NIBIB NIH HHS; R01 AG040019/AG/NIA NIH HHS; R21 AG034641/AG/NIA NIH HHS|
Journal ID (nlm-journal-id): 0410462
Journal ID (pubmed-jr-id): 6011
Journal ID (nlm-ta): Nature
Journal ID (iso-abbrev): Nature
nihms-submitted publication date: Day: 19 Month: 10 Year: 2012
Electronic publication date: Day: 05 Month: 12 Year: 2012
Print publication date: Day: 17 Month: 1 Year: 2013
pmc-release publication date: Day: 17 Month: 7 Year: 2013
Volume: 493 Issue: 7432
First Page: 433 Last Page: 436
PubMed Id: 23222518
|Mammalian Heart Renewal by Preexisting Cardiomyocytes|
|Samuel E. Senyo1|
|Matthew L. Steinhauser1|
|Christie L. Pizzimenti1|
|Vicky K. Yang1|
|Claude P. Lechene45|
|Richard T. Lee16|
1Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
2INSERM, U.759, F-91405 Orsay (France)
3Institut Curie, Laboratoire de Microscopie Ionique, F-91405 Orsay (France)
4National Resource for Imaging Mass Spectrometry
5Genetics Division, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
6Harvard Stem Cell Institute
Although recent studies have revealed that heart cells are generated in adult mammals, the frequency and source of new heart cells is unclear. Some studies suggest a high rate of stem cell activity with differentiation of progenitors to cardiomyocytes1. Other studies suggest that new cardiomyocytes are born at a very low rate2,3,4, and that they may be derived from division of pre-existing cardiomyocytes. Thus, the origin of cardiomyocytes in adult mammals remains unknown. Here we combined two different pulse-chase approaches -- genetic fate-mapping with stable isotope labeling and Multi-isotope Imaging Mass Spectrometry (MIMS). We show that genesis of cardiomyocytes occurs at a low rate by division of pre-existing cardiomyocytes during normal aging, a process that increases by four-fold adjacent to areas of myocardial injury. Cell cycle activity during normal aging and after injury led to polyploidy and multinucleation, but also to new diploid, mononucleated cardiomyocytes. These data reveal pre-existing cardiomyocytes as the dominant source of cardiomyocyte replacement in normal mammalian myocardial homeostasis as well as after myocardial injury.
Despite intensive research, fundamental aspects of the mammalian heart’s capacity for self-renewal are actively debated5,6. Estimates of cardiomyocyte turnover range from less than 1% per year2,3,4 to more than 40% per year7. Turnover has been reported to either decrease3 or increase with age7, while the source of new cardiomyocytes has been attributed to both division of existing myocytes8 and to progenitors residing within the heart9 or in exogenous niches such as bone marrow10. Controversy persists regarding the plasticity of the adult heart in part due to methodological challenges associated with studying slowly replenished tissues. Toxicity attributed to radiolabeled thymidine11 and halogenated nucleotide analogues12 limits the duration of labeling and may produce direct biological effects. Tissue autofluorescence can reduce the sensitivity and specificity of immunofluorescent methods of detecting cell cycle activity5,13, including as cell cycle markers or incorporation of halogenated nucleotide analogues. The challenge of measuring cardiomyocyte turnover is further compounded by the faster rate of turnover of cardiac stromal cells relative to cardiomyocytes14.
We used Multi-isotope Imaging Mass Spectrometry (MIMS) to study cardiomyocyte turnover and to determine whether new cardiomyocytes are derived from preexisting myocytes or from a progenitor pool (Fig 1a). MIMS uses ion microscopy and mass spectrometry to generate high resolution quantitative mass images and localize stable isotope reporters in domains smaller than one micron cubed15,16,17. MIMS generates 14N quantitative mass images by measuring the atomic composition of the sample surface with a lateral resolution of under 50nm and a depth resolution of a few atomic layers. Cardiomyocyte cell borders and intracellular organelles were easily resolved (Fig 1b). Regions of interest can be analyzed at higher resolution, demonstrating cardiomyocyte-specific subcellular ultrastructure, including sarcomeres (Fig 1c, Supplemental Fig 1a). In all subsequent analyses, cardiomyocyte nuclei were identified by their location within sarcomere-containing cells, distinguishing them from adjacent stromal cells.
An immense advantage of MIMS is the detection of nonradioactive stable isotope tracers. As an integral part of animate and inanimate matter, they do not alter biochemical reactions and are not harmful to the organism18. MIMS localizes stable isotope tracers by simultaneously quantifying multiple masses from each analyzed domain; this enables the generation of a quantitative ratio image of two stable isotopes of the same element15. The incorporation of a tracer tagged with the rare stable isotope of nitrogen (15N) is detectable with high precision by an increase in 15N:14N above the natural ratio (0.37%). Nuclear incorporation of 15N-thymidine is evident in cells having divided during a one-week labeling period, as observed in the small intestinal epithelium, which turns over completely in 3–5 days16 (Fig 1d); in contrast, 15N-thymidine labeled cells are rarely observed in the heart (Fig 1e) after 1 week of labeling. In subsequent studies, small intestine was used as a positive control to confirm label delivery.
To evaluate for an age-related change in cell cycle activity, we administered 15N-thymidine for 8 weeks to three age groups of C57BL6 mice starting at day-4 (neonate), at 10-weeks (young adult) and at 22-months (old adult) (Supplemental Fig 2). We then performed MIMS analysis (Fig 2a, b, Supplemental Fig 3). In the neonatal group, 56% (±3% s.e.m., n=3 mice) of cardiomyocytes demonstrated 15N nuclear labeling, consistent with the well-accepted occurrence of cardiomyocyte DNA synthesis during post-natal development19. We observed a marked decline in the frequency of 15N-labeled cardiomyocyte nuclei (15N+CM) in the young adult (neonate= 1.00%15N+CM/day ±0.05 s.e.m. vs young adult=0.015% 15N+CM/day ±0.003 s.e.m., n=3 mice/group, p<0.001) (Fig 2a, c; Supplemental Fig 3). We found a further reduction in cardiomyocyte DNA synthesis in old mice (young adult=0.015%15N+CM/day ±0.003 s.e.m. vs. old adult=0.007 %15N+CM/day ±0.002 s.e.m., n=3/group, p<0.05) (Fig 2c). The observed pattern of nuclear 15N-labeling in cardiomyocytes is consistent with the known chromatin distribution pattern in cardiomyocytes20 (Supplemental Fig 1b) and was measured at levels that could not be explained by DNA repair (Supplemental Fig 4). Extrapolating DNA synthesis measured in cardiomyocytes over 8 weeks yields a yearly rate of 5.5% in the young adult and 2.6% in the old mice. Given that cardiomyocytes are known to undergo DNA replication without completing the cell cycle19,21,22, these calculations represent the upper limit of cardiomyocyte generation under normal homeostatic conditions, indicating a low rate of cardiogenesis.
To test whether cell cycle activity occurred in preexisting cardiomyocytes or was dependent on a progenitor pool, we performed 15N-thymidine labeling of double-transgenic MerCreMer/ZEG mice, previously developed for genetic lineage mapping (Fig 3a)23,24. MerCreMer/ZEG cardiomyocytes irreversibly express green fluorescent protein (GFP) after treatment with 4OH-tamoxifen, allowing pulse labeling of existing cardiomyocytes with a reproducible efficiency of approximately 80%. Although some have reported rare GFP expression by non-cardiomyocytes with this approach25, we did not detect GFP expression in interstitial cells isolated from MerCreMer/ZEG hearts nor did we detect GFP expression by Sca1 or ckit-expressing progenitors in histological sections (Supplemental Fig 5). Thus, during a chase period, cardiomyocytes generated from progenitors should be GFP−, whereas cardiomyocytes arising from preexisting cardiomyocytes should express GFP at a frequency similar to the background rate induced by 4OH-tamoxifen. We administered 4OH-tamoxifen for two weeks to 8 wk-old mice (n=4); during a subsequent 10-week chase, mice received 15N-thymidine via osmotic minipump (20μg/h). With MIMS analysis, we identified 35 15N-labeled cardiomyocyte nuclei (of 4190 analyzed) over 10 weeks, yielding a projected yearly rate of cardiomyocyte DNA replication of 4.4%. Extrapolating from prior reports of high stem cell-dependent cardiomyocyte turnover7, we had anticipated detecting >320 cardiomyocytes entering the cell cycle; these results exclude such a high rate of turnover (expected 15N+ cardiomyocytes=321; observed=35; Fisher’s exact<0.0001). Immunofluorescent staining for GFP was performed on adjacent sections and an observer unaware of MIMS analysis results assessed GFP status. Of 15N+ cardiomyocytes, 77% expressed GFP, a frequency essentially identical to that of surrounding 15N− cardiomyocytes (15N+ CM, 77% vs 15N− cardiomyocytes, 84%; Fisher’s exact=n.s.) (Table 1). If new cardiomyocytes were derived from progenitors, 15N+ cardiomyocytes would have been GFP− (expected=0/35; observed=27/35, Fisher’s exact<0.0001). These data reveal that 15N-labeled cardiomyocytes resulted from DNA synthesis by preexisting cardiomyocytes and exclude a substantial contribution from stem cells to cardiomyocyte replacement in the uninjured heart.
Cardiomyocytes can undergo DNA replication without completing the cell cycle. Although multinucleation and polyploidization occur during early post-natal development and in response to myocardial stress2,19, we considered the possibility these processes could account for 15N+ cardiomyocytes in the uninjured adult mouse. We performed fluorescent in situ hybridization in adjacent sections to assess the ploidy state of each 15N+ cardiomyocyte and surrounding 15N− cardiomyocytes, and an observer unaware of the results of MIMS analysis identified fluorescently-labeled chromosomes (Supplemental Fig 6). Although we found 15N+ cardiomyocytes that were polyploid (4n or greater), we observed a higher frequency of diploid nuclei in the 15N+ pool compared to surrounding 15N− cardiomyocytes (15N+ diploid:polyploid = 22:12 vs 15N− diploid:polyploid = 9:56, Fisher’s exact p<0.0001), consistent with ongoing cell division. We then assessed each cell for multinucleation using serial 0.5μm sections adjacent to the section used for MIMS analysis (Supplemental Fig 6). We observed that 49% of 15N+ cardiomyocytes were mononucleated, in contrast to a frequency of 24% for surrounding 15N− cardiomyocytes (Fisher’s exact p<0.01), also consistent with cell division. The majority of cardiomyocyte DNA synthesis occurred in polyploid and/or multinucleated cardiomyocytes as might be expected with a physiologic hypertrophic response and thus unlikely to indicate cardiomyocyte division; however, 17% (6 of 35 15N+ CM) were diploid and mononucleated, consistent with newly generated cardiomyocytes (Supplemental Fig 7). The mononucleated, diploid, 15N+ cardiomyocytes were also predominantly GFP+ (5 of 6 = 83% vs. 82% background frequency, p=n.s.), suggesting that they arose from preexisting cardiomyocytes at a slow annual rate of 0.76% (n=6 of 4190 over 10 weeks).
We next used MIMS and genetic fate mapping to study myocardial injury. Cardiomyocyte GFP labeling was induced in MerCreMer/ZEG mice with 4OH-tamoxifen. Mice then underwent experimental myocardial infarction or sham surgery followed by continuous labeling with 15N-thymidine for 8wks. The frequency of 15N-labeled cardiomyocytes in sham-operated mice was similar to prior experiments in unoperated mice (yearly projected rates: sham=6.8%; unoperated=4.4%), but increased significantly adjacent to infarcted myocardium (total 15N+ cardiomyocyte nuclei: MI=23.0% vs sham=1.1%, Fig 4a–b, Supplemental Fig 8). We examined GFP expression, nucleation and ploidy status of 15N-labeled cardiomyocytes and surrounding unlabeled cardiomyocytes. We found a significant dilution of the GFP+ cardiomyocyte pool at the border region as previously shown23,24 (67% vs. 79%, p<0.05, Table 2, Supplemental Fig 9); however, 15N+ myocytes demonstrated a similar frequency of GFP expression compared to unlabeled myocytes (71% vs. 67%, Fisher’s exact=n.s.), suggesting that DNA synthesis was primarily occurring in pre-existing cardiomyocytes. Of 15N-labeled cardiomyocytes, approximately 14% were mononucleated and diploid consistent with division of pre-existing cardiomyocytes (Supplemental Fig 6, 7). We observed higher DNA content (>2N) in the remaining cardiomyocytes as expected with compensatory hypertrophy after injury. Thus, in the 8wks after myocardial infarction, approximately 3.2% of the cardiomyocytes adjacent to the infarct had unambiguously undergone division (total 15N+ × mononucleated diploid fraction = 23% × 0.14 = 3.2%). The low rate of cardiomyocyte cell cycle completion is further supported by the absence of detectable Aurora B Kinase, a transiently expressed cytokinesis marker, which was detected in rapidly proliferating small intestinal cells but not in cardiomyocytes (Supplemental Fig 10). We also considered the possibility that a subset of 15N+ myocytes that were multinucleated and/or polyploid resulted from division followed by additional rounds of DNA synthesis without division. However, quantitative analysis of the 15N+ population did not identify a subpopulation that had accumulated additional 15N-label as would be expected in such a scenario (Supplemental Fig 11). Together, these data suggest that adult cardiomyocytes retain some capacity to reenter the cell cycle, but that the majority of DNA synthesis after injury occurs in preexisting cardiomyocytes without completion of cell division.
If dilution of the GFP+ cardiomyocyte pool cannot be attributed to division and differentiation of endogenous progenitors, do these data exclude a role for progenitors in the adult mammalian heart? These data could be explained by preferential loss of GFP+ cardiomyocytes after injury, a process that we have previously considered but for which we have not found supporting evidence23. Such an explanation excludes a role for endogenous progenitors in cardiac repair and would be consistent with data emerging from lower vertebrates8,26 and the neonatal mouse27 in which preexisting cardiomyocytes are the cellular source for cardiomyocyte repletion. A second possibility to explain the dilution of the GFP+ cardiomyocyte pool is that injury stimulates progenitor differentiation without division; inevitably, this would lead to exhaustion of the progenitor pool, which if true could explain the limited regenerative potential of the adult mammalian heart.
In summary, this study demonstrates birth of cardiomyocytes from preexisting cardiomyocytes at a projected rate of approximately 0.76%/year (15N+ annual rate × mononucleated diploid fraction = 4.4% × 0.17) in the young adult mouse under normal homeostatic conditions, a rate that declines with age but increases by approximately four-fold after myocardial injury in the border region. This study shows that cardiac progenitors do not play a significant role in myocardial homeostasis in mammals and suggests that their role after injury is also limited.
All experiments were conducted in accordance with the Guide for the Use and Care of Laboratory Animals and approved by the Harvard Medical School Standing Committee on Animals. C57Bl/6 male mice were obtained from Charles River.
We generated double transgenic Mer-CreMer-ZEG male mice by crossbreeding cardiomyocyte-specific MerCreMer mice and ZEG mice (Jackson Laboratory). β-galactosidase-GFP is under the control of a cytomegalovirus (CMV) enhancer/chicken actin promoter (Actb); the background strain was C57BL/6J (N7). The background strain of the MerCreMer mice was C57Bl/6SV129. Genotyping was performed by PCR on tail DNA using the following primers: MerCreMer forward: 5′-GTCTGAC TAGGTGTCCTTCT-3′; MerCreMer backward: 5′-CGTCCTCCTGCTGGTA TAG-3′; ZEG forward: 5′-AAGTTCATCTGCACCACCG-3′; ZEG backward: 5′-TCCTTGAAGAAGATGGTGCG-3′; ZEG control forward: 5′-CTAGGCCA CAGAATTGAAAGATCT-3′; and ZEG control backward: 5′-GTAGGTG GAAATTCTAGCATCATCC-3′. To induce Cre recombination and GFP labeling in cardiomyocytes, we injected 4-OH-tamoxifen (provided by a generous gift from Laboratoires Besins), dissolved in peanut oil (Sigma) at a concentration of 5 mg/ml, intraperitoneally into 8-week-old MerCreMer-ZEG mice daily at a dosage of 0.5 mg/day for 14 days.
Mice were subjected to experimental myocardial infarction as described. Surgeries were performed by a single operator with more than 20 years of experience in the performance of coronary ligation in rodents. In brief, the left coronary artery was permanently ligated approximately 2 mm below the left atrial appendage. For sham operations, the thoracic cavity was opened and the heart exposed, but no intramyocardial sutures were placed. 15N-thymidine (Cambridge Isotopes) was administered at a rate of 20μg/hr via osmotic minipump (Alzet), implanted subcutaneously at the time of experimental myocardial infarction after a single intraperitoneal bolus dose of 500μg.
The factory prototype of the NanoSIMS50 as well as a standard NanoSIMS 50 and a large radius NanoSIMS 50L (Cameca, Gennevilliers, France) was used for MIMS analysis as previously described15. A focused beam of Cs+ ions was used to sputter a few atomic layers and generate secondary ions from the left ventricular free wall of heart section samples. The Cs+ primary ions were scanned over a raster pattern of either 256 × 256 pixels or 512 × 512 pixels. At each pixel location, the secondary ion intensities for 12C−, 13C−, 12C14N− and 12C15N−were recorded in parallel from the same sputtered volume. The detection of nitrogen requires the use of cluster ions 12C14N− and 12C15N− for 14N and 15N, respectively, due to the low ionization efficiency of nitrogen as N−.
From a single field image acquisition, we first extracted four image files: the four original quantitative mass images (QMIs; 12C, 13C, 12C14N, 12C15N) and the two ratio images (13C/12C and 12C15N/12C14N), derived from the pixel-by-pixel division of the 13C QMI by the 12C QMI and of the 12C15N QMI by the 12C14N QMI, respectively. We then used a hue saturation intensity transformation (HSI) of the ratio image to map 15N-labeled regions. The hue corresponds to the ratio value, and the intensity at a given hue is an index of statistical reliability.
For the neonatal cohort in the aging experiment, labeling was starting at post-natal day 4 with subcutaneous injections of 50μg/g 15N-thymidine (Cambridge Isotopes) every 12h and continued through post-natal week 4. Starting at age 4 wks – and in all other experiments using adult mice – osmotic minipumps (Alzet) were implanted subcutaneously, delivering 15N-thymidine (Cambridge Isotopes) at a rate of 20 μg/hour.
Serial adjacent sections (0.5μm) were stained to identify cardiomyocyte borders. A given cardiomyocyte was tracked in the vertical axis by locating it in serial sections. Uninjured hearts were stained using a modified PAS protocol with standard solutions (Electron Microscopy Services), but with longer incubation times optimized for LR white embedding. Slides were incubated in xylene at 37C, 1 hour, rehydrated through graded alcohols, incubated in periodic acid for two hours, and Schiff’s reagent for two nights. Sections were counterstained in hematoxylin and Scott’s Bluing for 1 hour each. Injured hearts were stained using a modified Trichrome staining protocol with standard solutions (Fisher Scientific), but with longer incubation times. Slides were incubated in xylene at 37C, 1 hour, rehydrated through graded alcohols, incubated in bouin’s fluid at 56C, 1 hour, rinsed in tap water, incubated in weigert’s iron hematoxylin stain 1 hour, rinsed in tap water, incubated in scarlet-acid fuchsin solution, 1 hour, rinsed in DI water, incubated in phophotungistic-phophomolybdic acid solution, 30 minutes, incubated in aniline blue stain solution, 30 minutes, and incubated in 1% acetic acid, 20 minutes.
Sections were incubated in proteinase K (50ug/ml) at 60C for 15min. After a PBS/MgCl2 (45mM) wash, slides were post-fixed in 4% paraformaldehyde (PBS/MgCl2), dehydrated through graded alcohols. Biotinylated-labeled chromosome Y paint (Star-FISH, Cambio) in hybridization mix was applied to sections, and sealed under glass with rubber cement (note some samples were analyzed with chromosome-18 paint due to product discontinuation of Y-paint). Samples were heated to 90C for 15 min. After an overnight incubation at 37C, slides were washed three times with 50% formamide/2x standard saline citrate at 45C, three washes with 2x standard saline citrate at room temperature, and two washes with 4x standard saline citrate/0.1% Tween at room temperature. Samples were blocked 10 minutes with 4x standard saline citrate/0.1% Tween/ 0.05% milk and incubated for 2 hr in streptavidin-conjugated Alexa Fluor 488 (Invitrogen) prior to washing and mounting. An observer unaware of the MIMS images or 15N-thymidine labeling status of the nuclei assigned ploidy status.
Sections were incubated in glycine/tris (50mM glycine/0.05M Tris) at room temperature for 5min. After a brief wash with Tris, sections were incubated with chicken anti-GFP (Abcam), rabbit anti-ckit (Abcam), rat anti-sca1 (Abcam) with fresh 0.1%BSA in TBST (TBS/0.1%Tween) overnight at 4C. After a brief wash with TBS, sections were incubated with anti-chicken Alexa Fluor 488 (Invitrogen) prior to TBS wash and mounting. An observer unaware of the MIMS images or 15N-thymidine labeling status of the nuclei assigned GFP status.
We used a custom-written script in IP Lab version 4.0 (Scanalytics) imaging software for serial image acquisition. Tissue sections were auto-imaged using an Olympus IX-70 microscope with a digital charge-coupled device camera (CoolSNAP EZ, Roper Scientific), an automated stage with a piezoelectric objective positioner (Polytec PI, Auburn MA) to compensate for deviations in the z-axis. Images were compressed and stitched into a mosaic using stitching software (Canon Photostitch). Multichannel images were merged in ImageJ prior to stitching.
Statistical testing was performed using Prism 3.0 (Graphpad). Results are presented as mean ± s.e.m. and were compared using T-tests (significance was assigned for p<0.05). Data comparing event rates were tested with a Fisher-Exact test.
S.E.S., M.L.S. and R.T.L. designed the experiments. S.E.S., M.L.S., and V.K.Y. performed the experiments. L.C., C.L.P., V.K.Y., M.L.S., and S.E.S. performed histology. M.W. and S.E.S. operated the prototype nanoSIMS instrument. T-D.W. and J-L.G-K. operated nanoSIMS instrument at Curie. S.E.S. and M.L.S. analyzed the data with input from C.P.L. and R.T.L. C.P.L. supervised all MIMS analyses and provided critical feedback at all junctures. S.E.S. and M.L.S. made the figures. S.E.S., M.L.S., and R.T.L. wrote the manuscript. All authors approved the manuscript.
The authors thank J. Gannon for surgical assistance, J. Lammerding and P. Isserman with assistance with microscopy and IP Lab software. We thank the PICT-IBiSA Imaging Facility in the Institut Curie. We thank Catherine MacGillivray for histology. S.E.S is funded by the National Institutes of Health (F32 HL108570). M.L.S. is funded by the American Heart Association (AHA FTF), Future Leaders in Cardiovascular Medicine, Watkins Cardiovascular Leadership Award and the NIH (K08 DK090147). C.P.L. is funded by the National Institutes of Health (EB001974, AG034641) and the Ellison Medical Foundation (AG-SS-2215-08). R.T.L is funded by the National Institutes of Health (AG032977, AG040019).
|1.||Hosoda T,et al. Clonality of mouse and human cardiomyogenesis in vivoProc Natl Acad Sci U S A1061716917174Year: 200919805158|
|2.||Soonpaa MH,Field LJ. Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse heartsAm J Physiol Heart Circ Physiol272H220226Year: 1997|
|3.||Bergmann O,et al. Evidence for cardiomyocyte renewal in humansScience32498102Year: 200919342590|
|4.||Walsh S,Ponten A,Fleischmann BK,Jovinge S. Cardiomyocyte cell cycle control and growth estimation in vivo--an analysis based on cardiomyocyte nucleiCardiovasc Res86365373Year: 201020071355|
|5.||Laflamme MA,Murry CE. Heart regenerationNature473326335Year: 201121593865|
|6.||Hosoda T,Rota M,Kajstura J,Leri A,Anversa P. Role of stem cells in cardiovascular biologyJ Thromb Haemost9Suppl 1151161Year: 201121781250|
|7.||Kajstura J,et al. Myocyte turnover in the aging human heartCirc Res10713741386Year: 201021088285|
|8.||Kikuchi K,et al. Primary contribution to zebrafish heart regeneration by gata4(+) cardiomyocytesNature464601605Year: 201020336144|
|9.||Beltrami AP,et al. Adult cardiac stem cells are multipotent and support myocardial regenerationCell114763776Year: 200314505575|
|10.||Orlic D,et al. Bone marrow cells regenerate infarcted myocardiumNature410701705Year: 200111287958|
|11.||Hu VW,Black GE,Torres-Duarte A,Abramson FP. 3H-thymidine is a defective tool with which to measure rates of DNA synthesisFaseb J1614561457Year: 200212205046|
|12.||Wilson A,et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repairCell13511181129Year: 200819062086|
|13.||Laflamme MA,Murry CE. Regenerating the heartNat Biotechnol23845856Year: 200516003373|
|14.||Bergmann O,et al. Identification of cardiomyocyte nuclei and assessment of ploidy for the analysis of cell turnoverExp Cell Res317188194Year: 201020828558|
|15.||Lechene C,et al. High-resolution quantitative imaging of mammalian and bacterial cells using stable isotope mass spectrometryJ Biol5130Year: 200616515716|
|16.||Steinhauser ML,et al. Multi-isotope imaging mass spectrometry quantifies stem cell division and metabolismNature481516519Year: 201222246326|
|17.||Zhang DS,et al. Multi-isotope imaging mass spectrometry reveals slow protein turnover in hair-cell stereociliaNature481520524Year: 201222246323|
|18.||Klein PD,Klein ER. Stable isotopes: origins and safetyJ Clin Pharmacol26378382Year: 19863734125|
|19.||Li F,Wang X,Capasso JM,Gerdes AM. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal developmentJ Mol Cell Cardiol2817371746Year: 19968877783|
|20.||Nikolova V,et al. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient miceJ Clin Invest113357369Year: 200414755333|
|21.||Adler CP,Friedburg H. Myocardial DNA content, ploidy level and cell number in geriatric hearts: post-mortem examinations of human myocardium in old ageJ Mol Cell Cardiol183953Year: 19863950970|
|22.||Katzberg AA,Farmer BB,Harris RA. The predominance of binucleation in isolated rat heart myocytesAm J Anat149489499Year: 1977906968|
|23.||Hsieh PC,et al. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injuryNat Med13970974Year: 200717660827|
|24.||Loffredo FS,Steinhauser ML,Gannon J,Lee RT. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repairCell Stem Cell8389398Year: 201121474103|
|25.||Dong F,et al. Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarctionCirculation12631432422685115|
|26.||Jopling C,et al. Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferationNature464606609Year: 201020336145|
|27.||Porrello ER,et al. Transient regenerative potential of the neonatal mouse heartScience33110781080Year: 201121350179|
Previous Document: Seventy-five genetic loci influencing the human red blood cell.
Next Document: Controlling dielectrics with the electric field of light.